Tyrosine kinase inhibitors (TKIs) are a class of targeted cancer therapies designed to block the action of enzymes known as tyrosine kinases. Tyrosine kinases play a crucial role in the signaling pathways that regulate cell division, survival, and growth. When these enzymes malfunction, they can contribute to the development and progression of cancer. TKIs aim to interfere with these malfunctioning enzymes to halt cancer growth.
